TABLE 2.
Case number | Relationship | Age (y) | EBV (copies/μg) | Gene | Protein | 1000 genome | SIFT (<0.05) |
---|---|---|---|---|---|---|---|
Case 1 | Proband | 14 | (1.2 0.1) × 107 | AP3B1 | S671F | – | 0.049 (Damaging) |
Father | 40 | <5 × 102 | Normal | – | |||
Mother | 39 | <5 × 102 | AP3B1 | S671F | |||
Brother | 0.75 | <5 × 102 | AP3B1 | S671F | |||
Case 2 | Proband | 18 | (3.3 0.5) × 107 | LYST | H151R | – | 0.042 (Damaging) |
UNC13D | S919F | – | 0.699 (Tolerated) | ||||
Father | 50 | <5 × 102 | LYST | H151R | |||
Mother | 49 | <5 × 102 | UNC13D | S919F | |||
Case 3 | Proband | 25 | (5.4 1.5) × 105 | PRF1 | G306S | – | 0.010 (Damaging) |
PRF1 | P22RfsX29 | – | – | ||||
Father | 48 | (4.1 1.1) × 103 | PRF1 | P22RfsX29 | |||
Mother | 47 | <5 × 102 | PRF1 | G306S | |||
Brother | 23 | <5 × 102 | PRF1 | G306S | |||
PRF1 | P22RfsX29 | ||||||
Son | 1 | (3.2 0.8) × 103 | PRF1 | G306S | |||
Case 4 | Proband | 45 | (1.90.3) × 107 | STX11 | R49Q | 0.02 | 1.000 (Tolerated) |
PRF1 | R225Q | – | 0.366 (Tolerated) | ||||
Father | 70 | <5 × 102 | STX11 | R49Q | |||
Mother | 69 | <5 × 102 | PRF1 | R225Q | |||
Brother | 47 | <5 × 102 | STX11 | R49Q | |||
Brother | 43 | <5 × 102 | PRF1 | R225Q | |||
Sister | 40 | <5 × 102 | PRF1 | R225Q | |||
Son | 16 | <5 × 102 | PRF1 | R225Q | |||
Daughter | 18 | <5 × 102 | STX11(hom) | R49Q | |||
Husband | 48 | <5 × 102 | STX11 | R49Q | |||
Case 5 | Proband | 12 | (1.3 0.4) × 107 | ITK | R581W | 0.001 | 0.007 (Damaging) |
Father | 39 | <5 × 102 | Normal | ||||
Mother | 37 | <5 × 102 | ITK | R581W | |||
Case 6 | Proband | 25 | (7.7 1.9) × 105 | STXBP2 | R566G | 0.012 | 0.035 (Damaging) |
Father | 50 | <5 × 102 | Normal | ||||
Mother | 49 | <5 × 102 | STXBP2 | R566G | |||
Elder Sister | 27 | <5 × 102 | STXBP2 | R566G | |||
Younger Sister | 23 | <5 × 102 | Normal | ||||
Case 7 | Proband | 21 | (1.30.7) × 107 |
UNC13D UNC13D |
G863D A397T |
0.001 ‐ |
0.000 (Damaging) 0.262 (Tolerated) |
Father | 45 | <5 × 102 | UNC13D | G863D | |||
Mother | 44 | <5 × 102 | UNC13D | A397T | |||
Case 8 | Proband | 18 | (6.51.3) × 107 |
UNC13D UNC13D |
G863D I410L |
0.001 0.003 |
0.000 (Damaging) 1.000 (Tolerated) |
Father | 43 | <5 × 102 |
UNC13D UNC13D |
G863D I410L |
|||
Mother | 42 | <5 × 102 | Normal | ||||
Case 9 | Proband | 32 | (4.0 1.1) × 106 | GZMB | R120W | – | 0.031 (Damaging) |
Father | 54 | (1.2 0.3) × 103 | GZMB | R120W | |||
Mother | 53 | <5 × 102 | Normal | – | |||
Sister | 35 | <5 × 102 | GZMB | R120W | |||
Case 10 | Proband | 13 | (1.20.4) × 107 | RAB27A | R187Q | 0.009 | 0.372 (Tolerated) |
Father | 38 | <5 × 102 | RAB27A | R187Q | |||
Mother | 36 | (1.20.6) × 104 | Normal | – | |||
Brother | 8 | <5× 102 | Normal | – |
1000 genome, also known as 1000 genome project, is a map of human genome variation from population‐scale sequencing, the number stands for the frequency of amino acid substitution in the database. "‐" means amino acid substitution can't be detected in the database. SIFT predicts whether an amino acid substitution affects protein function. The lower the score, the more likely to be harmful.
Abbreviations: hom, homozygote; y, year.